Iovance Biotherapeutics Inc. buy Barclays PLC
Start price
25.02.26
/
50%
€3.57
Target price
25.02.27
€9.33
Performance (%)
-9.18%
Price
02.03.26
€3.25
Summary
This prediction is currently active. With a performance of -9.18%, the BUY prediction by Barclays_PLC is trending in the wrong direction. This prediction currently runs until 25.02.27. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Iovance Biotherapeutics Inc. | -9.18% |
| iShares Core DAX® | -0,38 % |
| iShares Nasdaq 100 | -0,41 % |
| iShares Nikkei 225® | 1,84 % |
| iShares S&P 500 | -0,71 % |
Comments by Barclays_PLC for this prediction
In the thread Iovance Biotherapeutics Inc. diskutieren
Iovance Biotherapeutics (IOVA) had its price target raised by Barclays PLC from $10.00 to $11.00. They now have an "overweight" rating on the stock.
Ratings data for IOVA provided by MarketBeat
Stopped prediction by Barclays_PLC for Iovance Biotherapeutics Inc.
Iovance Biotherapeutics Inc.
Start price
Target price
Perf. (%)
€2.44
24.12.25
24.12.25
€8.47
24.12.26
24.12.26
32.97%
02.03.26
02.03.26
Iovance Biotherapeutics Inc.
Start price
Target price
Perf. (%)
€1.63
12.05.25
12.05.25
€3.56
12.05.26
12.05.26
98.71%
02.03.26
02.03.26
Iovance Biotherapeutics Inc.
Start price
Target price
Perf. (%)
€3.00
14.04.25
14.04.25
€4.39
14.04.26
14.04.26
8.25%
02.03.26
02.03.26
Iovance Biotherapeutics Inc.
Start price
Target price
Perf. (%)
€15.05
29.02.24
29.02.24
€20.28
28.02.25
28.02.25
-73.24%
01.03.25
01.03.25